Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus. - Wikidata - wikimedia - TriplyDB

Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.

Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.

http://www.wikidata.org/entity/Q36898706

about

Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteins Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates Interplay between innate immunity and negative-strand RNA viruses: towards a rational model Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin.Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus.Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Biomarkers in Japanese encephalitis: a review.Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain.Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms.Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses

P2860

Q33579385-901992DA-369D-43E5-8844-5BCF24956306 Q33725635-194311F7-9CA4-458A-93F4-C43EB0C5CB84 Q33826779-E1BDF5D0-1F00-457B-A8E7-644A3E45B3CC Q33832168-E19605D6-A7BA-4BC8-996B-AD9B10719BA3 Q34212787-FED87B5A-06EF-40AE-9005-F66ADFE12AA8 Q34296055-8D451A58-DCD8-4E83-BA63-B1BD7D7147C1 Q34806497-44BC5944-2B9E-4B7A-975D-9D5348777F93 Q35641491-785700D6-A5F5-4510-A3BC-CA930135EBD7 Q35760520-841AB242-06DA-43CF-B966-181B5BEF19DF Q35867988-6A0BD66B-4EF0-4B54-8E23-E7EF0D2CB9D1 Q36611663-0C11562D-C860-496D-9ACD-70B53414863E Q36928622-EC0C0CA7-5664-4A7D-97F9-AD915181F70B Q37123143-EDF8DF35-1B29-4B38-BDD2-B9E97BD68A80 Q37325067-301B3D31-A38E-45DE-B7ED-47CD5009DAAE Q37425963-718FD1C3-5CC1-4F65-B823-271EE16DC146 Q37646792-B4F06C1E-C056-4B69-ADF4-AEC0BFF48D35 Q37713979-FEC790E7-0817-4A04-A530-9C2CC618B1B5 Q39096636-9D4BBB4E-67E6-415D-BFED-B05C0B753BB2 Q39224943-BF7C6713-0EA3-4916-B8E2-CF3EE3B234A9 Q39413447-CE7B5D09-330D-40C3-8A2E-374EBAD4E170 Q39804428-026BEC04-FE11-49A7-BAAA-900CBB2EBA9B Q41379521-B9B542F4-0EF0-4976-B572-4AD952D9917E Q41820076-5C2F6086-9CDE-4284-89DA-91D92E9227FB Q42273541-00EEE79A-8DDA-4C59-981E-7F344F6FDF57 Q42795549-C1E2FEAD-EF2F-4D79-A7B0-1A195A6CA753 Q43163173-43FA3356-6BC6-4ABA-921E-680C46BEA00F Q53699705-D811FB3A-43F4-4B7B-9B75-B299BD95158E Q57197569-B2D4AB66-ED98-48FA-882A-3C420C87116E Q58999704-3CAD6ED7-BCF7-42AA-B009-95B12F5CE06F

P2860

Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.

http://www.wikidata.org/entity/Q36898706

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Immune response in the absence ...... nt vesicular stomatitis virus.

@en

type

label

Immune response in the absence ...... nt vesicular stomatitis virus.

@en

prefLabel

Immune response in the absence ...... nt vesicular stomatitis virus.

@en

P1433

Q36898706-C9EF8A00-DDE8-44C7-8B57-F888C00D14F0

P1476

Q36898706-5B2032CF-54F8-4BC9-B738-E99AE0556FF0

P2093

Q36898706-03F6671F-BD4C-43DC-B369-2FD0E090EDE9

Q36898706-1334D124-6589-4E9B-8B0A-8335AB571D31

Q36898706-5121290B-0644-4C4A-99E8-913928DA74C5

Q36898706-9A3A5379-88F4-4B18-90A5-7F00FACCFB7C

Q36898706-E4D93D15-8A2D-47BF-9789-576DF6E4B0D1

P2860

Q36898706-068C39B4-66A7-41CC-A7F7-5402A6CF10E2

Q36898706-0EF59B32-3C37-4A9E-8FA5-CF3D7C467C7A

Q36898706-1C5BB5B8-417D-430C-8721-5061E185DBE7

Q36898706-27F32978-582C-4DB7-BA01-71EE17B912E7

Q36898706-406A6C88-3295-4FE9-8378-232BF8C57ED6

Q36898706-417DF4A5-8D56-4712-8A1C-EF16658A9512

Q36898706-420A5D48-39C7-49C2-93EC-C1D84F840BEB

Q36898706-477CA8E9-C0FA-40A9-850C-30DE723179C3

Q36898706-5D5DE584-2323-486C-9DFC-404CCA22FE91

Q36898706-69D48338-BCBD-40AD-A84A-B5C65E5096A9

P304

Q36898706-A38B7845-0B78-44C7-9DEC-DCDBB7CDB3DC

P31

Q36898706-E60108DF-958C-498F-82A3-4C82BAB35D46

P356

Q36898706-BC0816AD-EDDD-4353-B0D1-F34C9FEEC45A

P407

Q36898706-BDBAF8E8-6E70-4A17-8248-95722716DC0E

P433

Q36898706-327A82D4-411F-4AC9-A992-BCECC5D409E9

P478

Q36898706-3864CA73-1E32-4640-88CE-72DFA42DC610

P577

Q36898706-8835CC4D-B772-4529-AE47-53AAA00668F3

P698

Q36898706-43306B1D-03DE-402F-890C-93F96C49E7A7

P932

Q36898706-BF6B1096-1DB0-4E7F-A41A-46C2A0B9517B

P356

P1433

Journal of Virology

P1476

Immune response in the absence ...... nt vesicular stomatitis virus.

@en

P2093

Douglas S Lyles

http://www.w3.org/2001/XMLSchema#string

Maryam Ahmed

http://www.w3.org/2001/XMLSchema#string

Nancy D Kock

http://www.w3.org/2001/XMLSchema#string

Shelby Puckett

http://www.w3.org/2001/XMLSchema#string

Tracie R Marino

http://www.w3.org/2001/XMLSchema#string

P2860

Attenuated vesicular stomatitis viruses as vaccine vectors

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Cytopathogenesis and inhibition of host gene expression by RNA viruses.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.

Influenza vaccines: present and future.

Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha

P304

9273-9277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00915-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18614644

http://www.w3.org/2001/XMLSchema#string

P932

2546904

http://www.w3.org/2001/XMLSchema#string